Doseology Sciences Inc. (CSE:MOOD)

Market Cap	5.33M
Revenue (ttm)	n/a
Net Income (ttm)	n/a
Shares Out	7.84M
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,510
Average Volume	10,843
Open	0.7400
Previous Close	0.7500
Day's Range	0.6800 - 0.7400
52-Week Range	0.0850 - 1.9000
Beta	-2.97
RSI	56.01
Earnings Date	n/a

About Doseology Sciences

Doseology Sciences Inc., through its subsidiary, Dose Labs Inc., engages in the research, development, and sale of functional mushroom products with a focus on mental health research in Canada. The company also offers medicinal mushroom products, including tinctures. It sells its products online through doseology.com and e-commerce platforms, as well as through various retail chains and distributors. The company was formerly known as Pcybin Therapeutic Inc. and changed its name to Doseology Sciences Inc. in January 2020. Doseology Sciences Inc....

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2019
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: MOOD